NCT02669524View on ClinicalTrials.gov

Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Type 2 Diabetes
Interventions
DRUG

LY2409021

DRUG

LY2409021 placebo

PROCEDURE

OGTT

PROCEDURE

IIGI

PROCEDURE

Standardised liquid meal

Trial Locations (1)

DK-2900

Center for Diabetes Research, Gentofte Hospital, Copenhagen University, Hellerup

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT02669524 - Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter